Ppi-dac Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PPI-DAC, and what generic and branded alternatives to PPI-DAC drugs are available?
PPI-DAC has four approved drugs.
Summary for Ppi-dac
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Ppi-dac
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ppi-dac | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 090685-002 | Oct 6, 2009 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ppi-dac | NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 090711-002 | Jul 10, 2009 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ppi-dac | CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | cetirizine hydrochloride; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 210719-001 | Nov 16, 2018 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ppi-dac | NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 203690-002 | Oct 9, 2012 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ppi-dac | NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 090711-001 | Jul 10, 2009 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
